Pharmacogenomics-Supported Psychotropic Prescribing Trial
Recruiting now NCT06929533
Run by University of Manitoba · for 18 and older · All sexes
What this study is about
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Who can join (things the study team will check)
✅ You may be able to join if…
- Aged 18 years or older
- The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
- The treating clinician thinks PGx testing can benefit and refers the patient to the study
🚫 You may not be able to join if…
- Unwillingness to donate saliva samples for genetic analysis
- History of liver or bone marrow (hematopoietic cell) transplantation
- PGx testing results are already available
- No personal health identification number (PHIN) is available
Where this trial is running
- Shared Health Facilities, Winnipeg, Manitoba, Canada
- University of Manitoba College of Pharmacy, Winnipeg, Manitoba, Canada
Who to contact
Abdullah Al Maruf, BPharm, MPharm, PhD · 204-318-2575 · abdullah.maruf@umanitoba.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06929533.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.